[Multidrug resistance (MDR) to cytostatics in proliferative diseases of the hematopoietic system].
Adamczyk-Cioch
M B
MB
Kliniki Hematologii Akademii Medycznej, Lublinie.
Dmoszyńska-Giannopoulau
A
A
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002462:Cell Membrane / Q000187:drug effects / Q000502:physiology; D004351:Drug Resistance / Q000235:genetics / Q000502:physiology*; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008562:Membrane Glycoproteins / Q000235:genetics / Q000502:physiology*
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D008562:Membrane Glycoproteins
Wielolekowa oporność na cytostatyki (multidrug resistance--MDR) w chorobach proliferacyjnych układu krwiotwórczego.